[{"orgOrder":0,"company":"NutraHeal","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Dietary Supplement","year":"2022","type":"Inapplicable","leadProduct":"Nutraheal","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"NutraHeal","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Capsule","sponsorNew":"NutraHeal \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"NutraHeal \/ Inapplicable"},{"orgOrder":0,"company":"Green Cross Wellbeing","sponsor":"Chung-Ang University Hosptial, Chung-Ang University College of Medicine","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Human Placenta Hydrolysate","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Green Cross Wellbeing","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Injection","sponsorNew":"Green Cross Wellbeing \/ Chung-Ang University Hosptial, Chung-Ang University College of Medicine","highestDevelopmentStatusID":"1","companyTruncated":"Green Cross Wellbeing \/ Chung-Ang University Hosptial, Chung-Ang University College of Medicine"},{"orgOrder":0,"company":"NYU Langone Health","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Dietary Supplement","year":"2025","type":"Inapplicable","leadProduct":"Xr Recovery Supplement","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"NYU Langone Health","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"NYU Langone Health \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"NYU Langone Health \/ Inapplicable"},{"orgOrder":0,"company":"University College Cork","sponsor":"Health Service Executive","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Other Small Molecule","year":"2021","type":"Inapplicable","leadProduct":"Lidocaine","moa":"Sodium channel alpha subunit","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"University College Cork","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University College Cork \/ Health Service Executive","highestDevelopmentStatusID":"1","companyTruncated":"University College Cork \/ Health Service Executive"},{"orgOrder":0,"company":"Dove Medical Press","sponsor":"The Affiliated Hospital of Qingdao University | Nakhia Impex","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Other Small Molecule","year":"2023","type":"Inapplicable","leadProduct":"Sodium Hyaluronate","moa":"CD44","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Dove Medical Press","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Solution","sponsorNew":"Dove Medical Press \/ The Affiliated Hospital of Qingdao University | Nakhia Impex","highestDevelopmentStatusID":"1","companyTruncated":"Dove Medical Press \/ The Affiliated Hospital of Qingdao University | Nakhia Impex"},{"orgOrder":0,"company":"Orthox","sponsor":"Parkwalk","pharmaFlowCategory":"D","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"UNITED KINGDOM","productType":"Protein","year":"2022","type":"Series A Financing","leadProduct":"Fibroin","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Orthox","amount2":0.01,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0.01,"dosageForm":"Implant","sponsorNew":"Orthox \/ Parkwalk","highestDevelopmentStatusID":"1","companyTruncated":"Orthox \/ Parkwalk"},{"orgOrder":0,"company":"Alternativa International S.A","sponsor":"Artialis","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Undisclosed","year":"2020","type":"Inapplicable","leadProduct":"Myostim","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Alternativa International S.A","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Alternativa International S.A \/ Artialis","highestDevelopmentStatusID":"1","companyTruncated":"Alternativa International S.A \/ Artialis"},{"orgOrder":0,"company":"Qianfoshan Hospital","sponsor":"Shandong Qilu Stem Cells Engineering Co., Ltd.","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Cell and Gene therapy","year":"2021","type":"Inapplicable","leadProduct":"Umbilical Cord Blood Mononuclear Cell","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Qianfoshan Hospital","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Injection","sponsorNew":"Qianfoshan Hospital \/ Shandong Qilu Stem Cells Engineering Co., Ltd.","highestDevelopmentStatusID":"1","companyTruncated":"Qianfoshan Hospital \/ Shandong Qilu Stem Cells Engineering Co., Ltd."},{"orgOrder":0,"company":"Regenexx","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"U.S.A","productType":"Undisclosed","year":"2022","type":"Inapplicable","leadProduct":"Platelet Rich Plasma","moa":"Growth factor","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Regenexx","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Regenexx \/ Inapplicable","highestDevelopmentStatusID":"1","companyTruncated":"Regenexx \/ Inapplicable"},{"orgOrder":0,"company":"Royal College of Surgeons, Ireland","sponsor":"Health Service Executive, Ireland","pharmaFlowCategory":"DU","therapeuticArea":"Orthopedics\/Orthopedic Surgery","country":"","productType":"Undisclosed","year":"2025","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Orthopedics\/Orthopedic Surgery","graph2":"Undisclosed","graph3":"Royal College of Surgeons, Ireland","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Orthopedics","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Royal College of Surgeons, Ireland \/ Health Service Executive, Ireland","highestDevelopmentStatusID":"1","companyTruncated":"Royal College of Surgeons, Ireland \/ Health Service Executive, Ireland"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Royal College of Surgeons, Ireland

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Royal College of Surgeons, Ireland

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Details : This drug candidate is currently being evaluated in clinical studies for the treatment of Hip Fractures.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          June 18, 2025

                          Lead Product(s) : Undisclosed

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Health Service Executive, Ireland

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Vitafoods
                          Not Confirmed
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          January 14, 2025

                          Lead Product(s) : Xr Recovery Supplement

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          Dove Medical Press

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Dove Medical Press

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          March 06, 2023

                          Lead Product(s) : Sodium Hyaluronate

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : The Affiliated Hospital of Qingdao University | Nakhia Impex

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Green Cross Wellbeing

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Green Cross Wellbeing

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Lead Product(s) : Human Placenta Hydrolysate

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Study Phase : Undisclosed

                          Sponsor : Chung-Ang University Hosptial, Chung-Ang University College of Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Laennec

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          September 06, 2022

                          Lead Product(s) : Human Placenta Hydrolysate

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Chung-Ang University Hosptial, Chung-Ang University College of Medicine

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Vitafoods
                          Not Confirmed
                          Vitafoods
                          Not Confirmed

                          Details : The financing will support further clinical trials of its lead product, FibroFix™, at Southmead Hospital Bristol, UK and in Budapest, Hungary. FibroFix is unique in emulating the functional properties of cartilage while also facilitating rapid tissue r...

                          Product Name : FibroFix

                          Product Type : Protein

                          Upfront Cash : Undisclosed

                          September 02, 2022

                          Lead Product(s) : Fibroin

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Parkwalk

                          Deal Size : $12.5 million

                          Deal Type : Series A Financing

                          blank

                          06

                          NutraHeal

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          NutraHeal

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          August 30, 2022

                          Lead Product(s) : Nutraheal

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Vitafoods
                          Not Confirmed
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          March 18, 2022

                          Lead Product(s) : Platelet Rich Plasma

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          University College Cork

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          University College Cork

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 12, 2021

                          Lead Product(s) : Lidocaine

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Health Service Executive

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Qianfoshan Hospital

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Qianfoshan Hospital

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Lead Product(s) : Umbilical Cord Blood Mononuclear Cell

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Study Phase : Undisclosed

                          Sponsor : Shandong Qilu Stem Cells Engineering Co., Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Cell and Gene therapy

                          Upfront Cash : Inapplicable

                          August 09, 2021

                          Lead Product(s) : Umbilical Cord Blood Mononuclear Cell

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Shandong Qilu Stem Cells Engineering Co., Ltd.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          Alternativa International S.A

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Alternativa International S.A

                          Country arrow
                          Vitafoods
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          December 28, 2020

                          Lead Product(s) : Myostim

                          Therapeutic Area : Orthopedics/Orthopedic Surgery

                          Highest Development Status : Undisclosed

                          Sponsor : Artialis

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank